Barratt Developments plc FY24 Interim Results
BP plc Group Results for the Fourth Quarter 2023
GSK’s Arexvy Vaccine Accepted for Priority FDA Review
GSK’s Shigrix Application Accepted for Review in China
GSK plc Announces Successful Phase III Trial for DREAMM-7
Vodafone Group plc Q3 FY 2024 Trading Update
Shell plc 4th Quarter 2023 and Full Year Unaudited Results
